chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Partial facial numbness near and around my left eye and cheek; This is a spontaneous report received from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: en6207) via an unspecified route of administration in right arm on 19Mar2021 at 11:15 (age at vaccination 41-years-old), as a single dose for COVID-19 immunisation. Medical history included seasonal allergies and gastroesophageal reflux disease (GERD). Concomitant medications included fexofenadine hydrochloride (ALLEGRA) and famotidine (MANUFACTURER UNKNOWN) both for unknown indication, from unknown date. The patient was allergic to amoxicillin. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 19Mar2021 at 15:00, the patient experienced partial facial numbness near and around her left eye and cheek. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported event numbness facial. The clinical outcome of the event numbness facial was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
While administering RV1 orally, patient vomited large amount of white (formula looking ) liquid.  Patient received about half of the RV1 dose. Mother of patient requested to not administer the rest of the RV1. Patient's temporal temperature was 99.1 F. No other systems noted. Mother requested that the Vaxelis and PCV be given in the right thigh.  Patient tolerated the intramuscular injections with issues and breastfed after shots with any further issues.
Info has been received from a health professional concerning a 9 week old male, with no medical history and no allergies, who on 6/2/06 was vaccinated with an oral dose of rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human-bovine) (Lot #653661/0146F). Concomitant therapy included generic acetaminophen about one hour before vaccination. Half way through the dose, on 6/2/06, the pt began to choke. He immediately developed a thick white coating on his tongue that came off in hard plaques. The pt became red in the face. The reporter tried to scrape the plaques off his tongue while they waited for the ambulance to transport the child to the ER. It was noted that the baby had been nursing on and off throughout the visit. At the time of the report, the pt had not recovered. A product quality complaint was involved (not further specified). Follow-up info from a health professional indicated that the pt was reported to have actually been given "Indermal", instead of rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human-bovine). The follow-up info indicated that a quality complaint was not involved. The reporter felt that the pt's reaction was an Other Important Medical Event, as he was transported to the ER. Additional info has been requested.
I positive for COVID-19 on 18FEB2023, I had a slight cough at the time. The next day I ran a low fever for couple of days and felt very tired. I didn't know I had COVID until I got tested. I also, was positive for influenzas type B at the same time. I was prescribed PAXLOVID, I started feeling better about 2 days after.
Pregnant when receiving both doses of vaccine; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant when receiving both doses of vaccine) in a 26-year-old female patient (gravida 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was in August 2020 and the estimated date of delivery was 01-Jun-2021. On 05-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant when receiving both doses of vaccine). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  On 30-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant when receiving both doses of vaccine) had resolved. Not Provided          Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.
A few days after receiving vaccination, the patient's mother noted a small area of redness and vesicles around the injection site. When examined in office, the patient had a 2" area of erythema, indurated, tender with papules. The patient also had otitis media. The patient was treated with Bactroban and Benadryl.
Malaise, Headache, chills and Chest pain with in the First hour of receiving the vaccines. Treated with Tylenol PRN.
After 2nd dose about 10 hours later was feeling sick; had terrible itching on feet and rash is back on chest; had terrible itching on feet and rash is back on chest; This is a spontaneous report from a contactable consumer or other non hcp (Patient) via Pfizer Sponsored Program COVAX US Support.  A male patient of an unspecified age received bnt162b2 (BNT162B2, formulation: solution for injection, Lot Number: Unknown, expiration date: unknown) via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (BNT162B2, formulation: solution for injection, Lot Number: Unknown, expiration date: unknown) via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunization and experienced small rash on his chest but did go away. On an unknown date, patient reported After 2nd dose about 10 hours later was feeling sick. Got up next morning had terrible itching on feet and rash is back on chest. Wondering if anyone else reported these symptoms. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Swelling, redness and pain at injection site, joint pain, body aches, sore throat. Sore throat, joint pain and body aches are better today however I still have swelling, redness and pain at injection site.
Started 5/25/19 , unilateral rash/blisters (left side-axillary,cheek, ear, thigh). Encouraged to rotate OTC Ibuprofen/Tylenol
Diagnosed with COVID-19 on 8/25/2021 emergency room., s/sx of cold/flu symptoms, fever, chills, fatigue, decreased appetite, chest pain and shortness of breath. Patient ended up intubated after acute MI in ER, admitted to hospital. Intubated until 8/28/2021 when family decided to admit to hospice as "this was not her wishes". Patient expired on 8/29/2021 at 0415
pt recv vax 29APR98 & exp hair loss in a circular area during APR-MAY98;the child's hair had been coming out in patches the size of a dime;
Had severe hives, joint pain, and developed a cough and sore throat.  The joint pain has been diagnosed as reactive arthritis by my PCP seeing as it was in my wrists, hands, ankles and feet on both sides of the body.  The started on my scalp and base of my neck and then moved to all over my body - hands, arms, legs, torso, feet, palms, soles of feet, etc.  I am still having some hives on my face, hands and arms.  I still have a cough at night and tightness in my chest at night.
He cried screamed a lot. He stopped rolling over, sitting alone, and starting to crawl. He stopped it all. Had a in home therapist come once a week to train him into doing all again. He had a second reaction also to MMR at age 1 1/2.
This spontaneous report as received from a health professional refers to an unspecified number of patient of unknown demographics. The concomitant medications, medical history and concomitant medications were unknown. On an unknown date in 2016 (reported as on or after 24-MAR-2016) the patients were vaccinated with unspecified number of improperly stored doses of PNEUMOVAX 23. The vaccine was stored at 47 F for 72. hours. There were no previous excursions. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
When pt was called to remind to get next shot in series of SHINGRIX, pt stated not interested because had swelling, flu like symptoms, and fever of greater than 101.
Fever, chills, headache, full body muscle pain, nausea starting 1:00 (starting 8 hours after vaccination) and lasting through the night and the entire day. Symptoms did not stop until the next day.
Stiffness in whole right arm with tingling and numbness in hands and fingers. Lasted about an hour after the injection.
Resident had sudden onset of extreme fatigue and weakness, and decreased appetite. Her left arm, injection site being left deltoid,  was firm, swollen, reddened, warm to touch, and painful
The patient told me that she had a rash/itch after her first ever dose of moderna covid vaccine so her doctor told her to take a benadryl before each future dose.  She forgot to take one this morning so she took a tablet right before her shot.  vaccine administration was around 12:25pm and as she was waiting afterwards she said she was feeling itchy /rash on her chest and feeling a little itchy on her face at 12:51pm  .I administered 25mg of liquid diphenhydramine at 12:56pm.
had a rash on her wrist; This is a spontaneous report from a contactable consumer (Patient). A 70-years-old female patient received first dose of bnt162b2 (Pfizer-Biontech COVID-19 Vaccine, solution for injection, Batch/Lot Number: unspecified) via an unspecified route of administration on 30Jan2021, as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient had a rash on her wrist on an unspecified date. She heard the second dose may cause a more severe reaction and was wondering if she should get the second vaccine or not? Patient asking what was the percentage of efficacy for the first vaccine for protection? The outcome of the event was unknown.  Follow-up attempts are completed. No further information is expected.
Occlusion of the left P2 segment of the left posterior cerebral artery; Acute left territory infarction; This initial spontaneous report was received from a lawyer regarding a case in litigation referring to a female patient of unknown age. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported. On or about 12-OCT-2017, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot #, expiration date, dosage and route of administration were not provided) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On 12-NOV-2017, reported as one month after receiveing zoster vaccine live (ZOSTAVAX), the patient suffered right sided numbness in her arm, facial droop and paresthesias. The patient was hospitalized and diagnosed with acute left territory infarction and occlusion of the left P2 segment of the left posterior cerebral artery. The patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury.   Upon internal review, infarction and cerebral artery occlusion were considered medically significant.    Infarction and cerebral artery occlusion were considered to be disabling due to the severe, permanent and incurable injuries.
Now months later I'm smelling it again; After my Moderna vaccine I smelled horrible smells; This spontaneous case was reported by a consumer and describes the occurrence of PAROSMIA (Now months later I'm smelling it again) and PAROSMIA (After my Moderna vaccine I smelled horrible smells) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAROSMIA (Now months later I'm smelling it again) and PAROSMIA (After my Moderna vaccine I smelled horrible smells). At the time of the report, PAROSMIA (Now months later I'm smelling it again) had not resolved and PAROSMIA (After my Moderna vaccine I smelled horrible smells) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Fever to 102.7 within 24 hours following immunization. No other symptoms, no signs of illness. No local immunization reaction
12OCT93 pt devel swelling of lower lips; no diff breathing or swallowing; no hives or urticaria; advised DPH & ice compresses; 13OCT93 lips inc swelling w/some improvement w/ice & DPH; advised to observe;
On 10/24/23 was in for a Fluzone vaccine a High dose Fluzone was given.  On 10/27/23 patient called in to the Health Department to report that her Flu shot that she received on 10/14/23, made her right arm start to go numb and swell about 3 hours after she received her shot.  States that her arm and hand was swollen so bad that she couldn't bend her arm or her and for several days.  10/27/23 today the swelling was down and she could move her arm and hand.  Had no other problems.  She wanted to report it to us.  This is when I realized that I gave her a High dose Fluzone when she should of had a regular Fluzone due to her age.  Her age was 57 years old.
Noticed fever 9-6-07. Noticed red-itchy bumps all over body 9-7-07.
Information has been received from a 70 year old female patient referring to herself. The patient had no concomitant medication, pertinent medical history or drug reactions/allergies. On 28-OCT-2016, the patient was vaccinated with PNEUMOVAX 23 (lot # was reported as M036826, expiration date 05-MAY-2016; 1 shot, route not reported). On the day of injection (28-OCT-2016), the patient experienced injection-site pain. The following day (29-OCT-2016) her arm had red blotches covering most of her arm and her arm doubled in size due to swelling. The patient didn't sought medical attention. Treatment was given for the events. The patient stated that she took BENADRYL and the swelling decreased a little. The patient also stated it was getting better by the reporting day. At the reporting time, the patient had not recovered. The causality was not reported. Additional information has been requested.
This spontaneous report was received from a 60 year old female Registered Nurse (R.N.) concerning herself. The patient's pertinent history included a case of shingles over 10 years ago. There were no drug allergies/drug reactions. On 03-JUN-2016, the patient was vaccinated with a dose of ZOSTAVAX subcutaneously (Lot # and dose were not reported). Concomitant therapies included metoprolol, calcium (unspecified), omega-3 marine triglycerides (fish oil) and vitamin C. On 03-JUN-2106, and within 1 hour of receiving the ZOSTAVAX, the patient experienced a reaction described as itching the size of a quarter at the injection site and a reddened area that was darker red in the center that was about 4cm with lighter color to the edges with a total area of 10 cm with induration. There were no vesicles present. The nurse sought medical attention by emailing an unspecified Nurse Practitioner (N.P.) on an unknown date. It was reported that the N.P. suggested using ZANTAC to lessen the reaction, however at the time of the report the nurse had not taken it. The unspecified N.P. also prescribed the following treatments that were administered by the nurse to herself: ice packs to the injection site, took unspecified dosage of BENADRYL and non-steroid anti-inflammatory medications as needed. There were no diagnostic laboratory tests performed. At the time of the report the outcome of the injection site pruritus, injection site induration and injection site erythema was not recovered. There was no overdose nor product quality complain involved. Additional information had been requested.
Feeling very weak unable to do normal errands, lightheaded, felt a little spacey/ detached, pulse rate sometimes elevated to 110 just sitting in a chair.  Blood pressure elevated. Took aspirin to thin my blood, and just rested. Symptoms gradually decreased over next 3 days to just occasional waves of weakness.  Now I'm fine again - a week after the shot.
experienced a leg cramp beginning Sunday, May 2. Went in to the ER Tuesday, May 11 with chest pains/short of breath. Diagnosed with bilateral pulmonary embolism. Put on blood thinners for next three months.
Person died on 5/7/2021 with death note stating acute respiratory failure with hypoxia, thrombocytopenia.
Past medical history of asthma with SOB developed shortly after receiving the COVID vaccine -Asthma exacerbation -Panic attack
Information has been received from an LPN concerning a 4 year old white male who on 12/9/97 was vaccinated with varicella virus vaccine live SC in the right thigh (lot 623654/0806E). On 1/26/01, the pt experienced chickenpox. Subsequently, the pt recovered from chickenpox. Additional information is not expected.
Severe reaction; Gingivitis; About 10-13 days ago, he was diagnosed with shingle; at first, they thought it was a bug bite since it started out as little pimples; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Severe reaction), GINGIVITIS (Gingivitis) and HERPES ZOSTER (About 10-13 days ago, he was diagnosed with shingle; at first, they thought it was a bug bite since it started out as little pimples) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.    In June 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In July 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Severe reaction), GINGIVITIS (Gingivitis) and HERPES ZOSTER (About 10-13 days ago, he was diagnosed with shingle; at first, they thought it was a bug bite since it started out as little pimples). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALTREX) ongoing since an unknown date for Shingles, at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (Severe reaction), GINGIVITIS (Gingivitis) and HERPES ZOSTER (About 10-13 days ago, he was diagnosed with shingle; at first, they thought it was a bug bite since it started out as little pimples) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient intakes unknown blood pressure medications and antibiotics for shingles as reported by the reporter.
Diarrhoea; Muscle spasms; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhoea), MUSCLE SPASMS (Muscle spasms) and FATIGUE (Fatigue) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced DIARRHOEA (Diarrhoea), MUSCLE SPASMS (Muscle spasms) and FATIGUE (Fatigue). At the time of the report, DIARRHOEA (Diarrhoea), MUSCLE SPASMS (Muscle spasms) and FATIGUE (Fatigue) had resolved.            No concomitant medication were reported.  No treatment information was provided.   Reporter did not allow further contact
FLUZONE (0.5cc IM (L) thigh) given on 11/7/11. Dad reports via phone call that "patient has hives" on 11/9/11 at 1600.
a bitter taste in her palate; feel weird her palate; lips shaking; anxious when biting her teeth; a sore arm; her ears shutting and then opening; fever; feels like climbing a mountain; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (a bitter taste in her palate), FEELING ABNORMAL (feel weird her palate), TREMOR (lips shaking), ANXIETY (anxious when biting her teeth) and PAIN IN EXTREMITY (a sore arm) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043B21A and 043B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced DYSGEUSIA (a bitter taste in her palate), FEELING ABNORMAL (feel weird her palate), TREMOR (lips shaking), ANXIETY (anxious when biting her teeth), PAIN IN EXTREMITY (a sore arm), EAR DISCOMFORT (her ears shutting and then opening), PYREXIA (fever) and FATIGUE (feels like climbing a mountain). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DYSGEUSIA (a bitter taste in her palate), FEELING ABNORMAL (feel weird her palate), TREMOR (lips shaking), ANXIETY (anxious when biting her teeth), PAIN IN EXTREMITY (a sore arm), EAR DISCOMFORT (her ears shutting and then opening), PYREXIA (fever) and FATIGUE (feels like climbing a mountain) outcome was unknown. Not Provided          No concomitant medication provided.  The action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to US-MODERNATX, INC.-MOD-2021-079035 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-079035:dose 1